Literature DB >> 28769466

FABRY'S DISEASE: A Case Report.

Abha K Sabhikhi1, P P Verma2, P S Reddy1, H Kumar3, Ramji Rai4.   

Abstract

Keywords:  Fabry's disease

Year:  2017        PMID： 28769466      PMCID： PMC5530889          DOI： 10.1016/S0377-1237(17)30688-3

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  7 in total

1.  Cardiovascular manifestations in Fabry's disease. A high incidence of mitral valve prolapse in hemizygotes and heterozygotes.

Authors:  H Sakuraba; Y Yanagawa; T Igarashi; Y Suzuki; T Suzuki; K Watanabe; K Ieki; K Shimoda; T Yamanaka
Journal:  Clin Genet       Date:  1986-04       Impact factor: 4.438

2.  Ceramide trihexosidosis (fabry's disease) without skin lesions.

Authors:  J T Clarke; J Knaack; J C Crawhall; L S Wolfe
Journal:  N Engl J Med       Date:  1971-02-04       Impact factor: 91.245

3.  Diagnostic value of kidney biopsy in heterozygous Fabry's disease.

Authors:  D Farge; S Nadler; L S Wolfe; P Barré; S Jothy
Journal:  Arch Pathol Lab Med       Date:  1985-01       Impact factor: 5.534

4.  Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy.

Authors:  M Elleder; V Bradová; F Smíd; M Budĕsínský; K Harzer; B Kustermann-Kuhn; J Ledvinová; V Král; V Dorazilová
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

5.  Outcome of end-stage renal disease in patients with rare causes of renal failure. I. Inherited and metabolic disorders.

Authors:  A R Nissenson; F K Port
Journal:  Q J Med       Date:  1989-11

6.  Angiokeratoma corporis diffusum with features of a mucopolysaccharidosis.

Authors:  D I McCallum; R F Macadam; A W Johnston
Journal:  J Med Genet       Date:  1980-02       Impact factor: 6.318

7.  Early renal failure in Fabry's disease.

Authors:  K J Sheth; D A Roth; M B Adams
Journal:  Am J Kidney Dis       Date:  1983-05       Impact factor: 8.860
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.